EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome

Armaiti Parvez Mody iD, Maya Beth Lodish iD, Richard Joseph Auchus, Adina F Turcu, Fei Jiang, Heather Gibson Huddleston

Endocrinology, Diabetes & Metabolism · 2025-01 · 8 (1)

DOI: 10.1002/edm2.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 15.01.2025. Verfasst von Armaiti Parvez Mody und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, University of California, Davis, California, USA. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Testosterone, Hyperandrogenism, Androgens. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Michigan Institute for Clinical and Health Research, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Hyperandrogenism is a hallmark of polycystic ovary syndrome (PCOS), yet the androgen(s) responsible remain ambiguous. Recent studies have suggested that 11‐oxygenated C 19 steroids (11‐oxyandrogens), specifically 11‐ketotestosterone, may be a good marker for hyperandrogenism in PCOS.

Objective

To investigate the utility of 11‐oxyandrogens to differentiate women with and without PCOS relative to classical androgens.

Design

Setting Case–control study performed at a PCOS clinic and research center in an academic setting. Patients 114 women with PCOS and 78 healthy controls.

Interventions

Using the PCOS Tissue Bank, serum samples and data from 114 women registered from 2013 to 2017 between the ages of 18–40 years, were obtained and classified using Rotterdam PCOS criteria. Data were compared to 78 healthy women of similar age, with serum samples obtained between 2017 and 2020. 11‐oxyandrogens and sex steroids were measured using mass spectrometry, and their associations to Rotterdam PCOS, age, and BMI were assessed. Main Outcome Measures 11‐oxyandrogens and sex steroids.

Results

Total testosterone, androstenedione, and four 11‐oxyandrogens were significantly elevated in women with PCOS compared to age matched controls, controlling for age and BMI ( p < 0.01 for all). When considered together, the four 11‐oxyandrogens were more predictive of PCOS compared to testosterone and androstenedione. When all androgens were considered individually, 11‐ketoandrostenedione was the most predictive of PCOS. Of the six androgens studied, 11‐ketotestosterone was the only androgen that demonstrated a weak association with hirsutism score ( r = 0.17; p = 0.07) within the PCOS group.

Conclusion

11‐oxyandrogens were statistically higher in women with PCOS and may serve as better predictors of PCOS than testosterone and androstenedione.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeTestosteroneHyperandrogenismAndrogensHumansFemaleAdultCase-Control StudiesYoung AdultAdolescentBiomarkersAndrostenedionePredictive Value of Tests

Stichwörter der Autor:innen

11‐ketotestosterone11‐oxygenated C19 steroidsandrogenshyperandrogenismpolycystic ovary syndrome

Substanzen

Testosterone11-ketotestosteroneBiomarkersAndrogensAndrostenedione

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology, University of California, Davis, California, USA.
  • Division of Pediatric Endocrinology, University of California, San Francisco, California, USA.
  • Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Epidemiology & Biostatistics, University of California, San Francisco, California, USA.
  • Division of Reproductive Endocrinology and Infertility, University of California, San Francisco, California, USA.

ORCID-Profile: Armaiti Parvez Mody, Maya Beth Lodish

Förderung

  • NIDDK NIH HHS
  • Michigan Institute for Clinical and Health Research
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Mody, A. P., Lodish, M. B., Auchus, R. J., Turcu, A. F., Jiang, F., & Huddleston, H. G. (2025). Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome. Endocrinology, Diabetes & Metabolism, 8(1). https://doi.org/10.1002/edm2.70022

Vancouver

Mody AP, Lodish MB, Auchus RJ, Turcu AF, Jiang F, Huddleston HG. Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome. Endocrinology, Diabetes & Metabolism. 2025;8(1). doi:10.1002/edm2.70022

BibTeX
@article{Mody2025,
  author = {Mody, Armaiti Parvez and Lodish, Maya Beth and Auchus, Richard Joseph and Turcu, Adina F and Jiang, Fei and Huddleston, Heather Gibson},
  title = {Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2025},
  volume = {8},
  number = {1},
  doi = {10.1002/edm2.70022}
}
Kostenlos starten →